Speed
119 days to first decision for reviewed manuscripts only
105 days to first decision for all manuscripts
170 days from submission to acceptance
31 days from acceptance to publication
Citation Impact
1.883 - 2-year Impact Factor
2.185 - 5-year Impact Factor
0.880 - Source Normalized Impact per Paper (SNIP)
0.980 - SCImago Journal Rank (SJR)
Usage
4,286,549 Downloads
5,758 Altmetric Mentions
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial
Early inhibition of entry and replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a very promising therapeutic approach. Polyclonal neutralizing antibodies offers many advantages...
Citation: Trials 2021 22:199